BCL-2 Inhibitor [EPC]

16619 reported adverse events

Drugs of this class: VENETOCLAX

These side effects are most commonly reported by patients taking drugs of the BCL-2 Inhibitor [EPC] class:

# Side effect Count
0 DEATH 3360
1 OFF LABEL USE 1813
2 PNEUMONIA 869
3 FATIGUE 790
4 PLATELET COUNT DECREASED 774
5 PYREXIA 726
6 NEUTROPENIA 678
7 INTENTIONAL PRODUCT USE ISSUE 664
8 DIARRHOEA 660
9 FEBRILE NEUTROPENIA 653
See all common reactions for BCL-2 Inhibitor [EPC]

Drugs of the BCL-2 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACUTE MYELOID LEUKAEMIA REFRACTORY 14 0.3182
1 MANTLE CELL LYMPHOMA REFRACTORY 12 0.3077
2 PROLYMPHOCYTIC LEUKAEMIA 6 0.2400
3 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 11 0.2075
4 URETERIC COMPRESSION 6 0.1935
5 T-CELL PROLYMPHOCYTIC LEUKAEMIA 8 0.1739
6 PLATELET TRANSFUSION 100 0.1600
7 CHRONIC LYMPHOCYTIC LEUKAEMIA 355 0.1246
8 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 46 0.1085
9 MYELOBLAST COUNT INCREASED 5 0.1064
See all enriched reactions for BCL-2 Inhibitor [EPC]